Zimbabwe recalls two batches of Nifedipine hypertension drug over quality concerns

In Zimbabwe, the quiet work of pharmaceutical oversight surfaced a concern that touches thousands of lives: two batches of Nifedipine, a medication many depend on daily to manage blood pressure and heart conditions, have been recalled after routine quality surveillance by the Medicines Control Authority. The recall is not a crisis, but it is a test — of how well a health system can communicate precisely enough to protect the vulnerable without triggering the kind of panic that leads people to abandon essential treatment. In a landscape where social media often moves faster than official guidan